Tisdale et al reported a score for predicting QTc interval prolongation in a hospitalized patient. The authors are from Purdue University, Indiana University and Krannert Institute of Cardiology.
Patient selection: hospitalized patient
Parameter:
(1) age in years
(2) sex
(4) serum potassium in mmol/L
(5) admission QTc in ms
(6) acute myocardial infarction
(7) number of QTc prolonging drugs
(8) sepsis
(9) heart failure
Parameter |
Finding |
Points |
age in years |
< 68 years |
0 |
|
>= 68 years |
1 |
sex |
male |
0 |
|
female |
1 |
loop diuretic |
no |
0 |
|
yes |
1 |
serum potassium |
> 3.5 mmol/L |
0 |
|
<= 3.5 mmol/L |
2 |
admission QTc |
< 450 ms |
0 |
|
>= 450 ms |
2 |
acute MI |
no |
0 |
|
yes |
2 |
number of QTc prolonging drugs |
0 |
0 |
|
1 |
3 |
|
>= 2 |
3 (or 6) |
sepsis |
no |
0 |
|
yes |
3 |
heart failure |
no |
0 |
|
yes |
3 |
total score =
= SUM(points for all 9 parameters)
Interpretation:
• minimum score: 0
• maximum score: 18 or 21 (21 is given in the paper; to achieve this a person would have to be scored for both 1 and GTE 2 QTc prolonging drugs. Effectively this means a person receiving GTE 2 drugs would be given 6 points)
• The higher the score the greater the risk for QTc prolongation.
Score |
Risk QTc Prolongation |
0 to 6 |
low |
7 to 10 |
moderate |
>= 11 |
high |
where:
• According to Figure 1 a score of 0 or 1 would have a very low risk.
• According to Figure 1 a score >= 16 would be very high.
Specialty: Cardiology